FDA Considers Approval for Moderna's mRNA-Based Flu Shot

The U.S. Food and Drug Administration is evaluating Moderna's mRNA-based flu vaccine, which could be the first of its kind on the market, a decision expected to impact the biotech industry.

1 Aug, 11:00 — 1 Aug, 11:00

Post Share

Sources

Showing 1 of 1 sources

NPRHigh2h ago

FDA weighs a new kind of flu shot based on technology RFK Jr. has questioned

The FDA is poised to render a decision on Moderna's mRNA-based flu shot, which could be the first of its kind to market. The decision is expected to reverberate throughout the biotech industry.

By Sydney Lupkin

Read full article →

PERSPECTA

PERSPECTA

FDA Considers Approval for Moderna's mRNA-Based Flu Shot

Sources

FDA weighs a new kind of flu shot based on technology RFK Jr. has questioned

Related Stories

Christopher Nolan's "The Odyssey" Film Success Boosts Game Interest, Fuels IMAX Debate

Tips for Preventing Mobile Phone Overheating in Summer

Experts Offer Advice on Managing Phone Use

South Korea's Crypto Tax Leads to Significant Drop in Trading Volume

PERSPECTA